The U.S. Food and Drug Administration approves Eli Lilly’s Zepbound drug for weight loss

The U.S. Food and Drug Administration approves Eli Lilly’s Zepbound drug for weight loss – CBS News

Watch CBS News


The FDA has approved Eli Lilly’s Zepbound drug for weight loss. It’s set to hit the market by the end of the year. Nancy Chen has more.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.